Comprehensive Review of Methods to Assess Uncertainty in Health Economic Evaluations

By HEOR Staff Writer

March 22, 2023

As healthcare costs continue to rise, accurate cost-effectiveness estimates are crucial. However, estimating the costs and outcomes of different interventions is complicated by uncertainty.

In model-based health economic evaluations (HEEs), uncertainty can arise from limited data, methodological limitations, and variability in clinical outcomes.

A recent review identified 80 methods for identifying, analyzing, and communicating uncertainty in HEEs. Quantifying uncertainty wherever possible is crucial to ensure accurate and unbiased cost-effectiveness estimates, ultimately leading to optimal allocation of healthcare resources

Reference url

Recent Posts

Rapid Genetic Testing Mitigates Gentamicin-Induced Hearing Loss in Neonates

By João L. Carapinha

March 9, 2026

Rapid genetic testing is dramatically improving neonatal care by detecting the m.1555A>G mitochondrial variant in newborns at risk of profound hearing loss from gentamicin, allowing swift switches to alternative antibiotics without delaying treatment. Developed through the
EMA’s Clinical Trials Guidance for Enhancing Flexibility During Public Health Emergencies
The European Medicines Agency (EMA) has released draft clinical trials guidance for public consultation from 4 March to 30 April 2026. This guidance outlines regulatory flexibi...
Portugal Clinical Trials Regulation: A Comprehensive Framework for EU Compliance and Participant ...
Portugal Aligns with EU Standards Portugal clinical trials regulation is now firmly established through Lei n.º 9/2026, published on March 6, 2026, which implements the European Parliament and Council